MyFinsight
Home
Blog
About
Back
Income Statement
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)
source: myfinsight.com
US
$91,633K
Europe
$19,283K
JP
$8,306K
Product revenue, net
$119,222K
(24.14%↑ Y/Y)
Income from operations
$58,417K
(48.62%↑ Y/Y)
Interest and other
income, net
$7,662K
(2.60%↑ Y/Y)
Total operating
expenses
$60,805K
(7.17%↑ Y/Y)
Income before income
taxes
$66,079K
(41.27%↑ Y/Y)
Selling, general and
administrative
$39,850K
(13.34%↑ Y/Y)
Research and development
$14,518K
(0.75%↑ Y/Y)
Cost of goods sold
$6,437K
(-10.16%↓ Y/Y)
Net income
$54,768K
(42.87%↑ Y/Y)
Income tax expense
$11,311K
(33.98%↑ Y/Y)
Comprehensive income
$52,056K
(33.14%↑ Y/Y)
Foreign currency
translation
-$1,499K
(-262.05%↓ Y/Y)
Unrealized (gain) loss on
available-for-sale securities
-$1,213K
(-667.72%↓ Y/Y)
Back